Xanthus Pharmaceuticals
Latest round
- Series B
Last raised
- Nov 2006
Total raised
- $56M
Investors
- 12
About Xanthus Pharmaceuticals
Xanthus Pharmaceuticals is a US-based bio pharmaceutical company that operates as a deveeloper of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
Who invested in Xanthus Pharmaceuticals
12 investors across 2 rounds
See all investors in Xanthus Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xanthus Pharmaceuticals
Who invested in Xanthus Pharmaceuticals?
Xanthus Pharmaceuticals has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xanthus Pharmaceuticals raised?
Xanthus Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Xanthus Pharmaceuticals last raise money?
Xanthus Pharmaceuticals's most recent round on record is a Series B, in Nov 2006.
What does Xanthus Pharmaceuticals do?
Xanthus Pharmaceuticals is a US-based bio pharmaceutical company that operates as a deveeloper of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
Where is Xanthus Pharmaceuticals headquartered?
Xanthus Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Xanthus Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Xanthus Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Xanthus Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.